Weekly Injected Drug Could Boost Outcomes for Patients With Type 2 Diabetes

TUESDAY, June 29, 2021 — People with type 2 diabetes face heightened risks for heart attack and stroke, as well as progressive kidney disease. But a new once-a-week injected drug called efpeglenatide could greatly reduce their odds for those…
Source: Topamax